UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Acute hepatitis C: Current status and remaining challenges

Journal of hepatology, 2008-10, Vol.49 (4), p.625-633

2008

Volltextzugriff (PDF)

Viral genotype-specific role of PNPLA3 , PPARG , MTTP, and IL28B in hepatitis C virus-associated steatosis

Journal of hepatology, 2011-09, Vol.55 (3), p.529-535

2011

Volltextzugriff (PDF)

Hepatitis C Virus Infection and Injection Drug Users: Prevention, Risk Factors, and Treatment

Clinical infectious diseases, 2005-04, Vol.40 (Supplement-5), p.S330-S335

2005

Volltextzugriff (PDF)

Association of Hepatitis C Virus—Specific CD8+ T Cells with Viral Clearance in Acute Hepatitis C

The Journal of infectious diseases, 2000-05, Vol.181 (5), p.1528-1536

2000

Volltextzugriff (PDF)

Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy

Hepatology (Baltimore, Md.), 2012-04, Vol.55 (4), p.1038-1047

2012

Volltextzugriff (PDF)

Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1–infected patients

Hepatology (Baltimore, Md.), 2009-08, Vol.50 (2), p.369-377

2009

Volltextzugriff (PDF)

Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection

Hepatology (Baltimore, Md.), 2005-03, Vol.41 (3), p.643-651

2005

Volltextzugriff (PDF)

Inhibition of Hepatitis C Virus-Like Particle Binding to Target Cells by Antiviral Antibodies in Acute and Chronic Hepatitis C

Journal of Virology, 2004-09, Vol.78 (17), p.9030-9040

2004

Volltextzugriff (PDF)

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance

Gastroenterology (New York, N.Y. 1943), 2003-07, Vol.125 (1), p.80-88

2003

Volltextzugriff (PDF)

Detection of functionally altered hepatitis C virus-specific CD4 + T cells in acute and chronic hepatitis C

Hepatology (Baltimore, Md.), 2003-05, Vol.37 (5), p.1189-1198

2003

Volltextzugriff (PDF)

Antibodies Against Hepatitis C Virus–Like Particles and Viral Clearance in Acute and Chronic Hepatitis C

Hepatology (Baltimore, Md.), 2000-09, Vol.32 (3), p.610-617

2000

Volltextzugriff (PDF)

The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus‐specific CD8+ T‐cell function

Hepatology (Baltimore, Md.), 2010-12, Vol.52 (6), p.1934-1947

2010

Volltextzugriff (PDF)

Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine

Vaccine, 2007-06, Vol.25 (26), p.4960-4966

2007

Volltextzugriff (PDF)

Prediction of treatment outcome in patients with chronic hepatitis C: Significance of baseline parameters and viral dynamics during therapy

Hepatology (Baltimore, Md.), 2003-03, Vol.37 (3), p.600-609

2003

Volltextzugriff (PDF)

Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination

Journal of hepatology, 2003-09, Vol.39 (3), p.397-404

2003

Volltextzugriff (PDF)

Importance of Minimal Residual Viremia for Relapse Prediction in Patients With Chronic Hepatitis C Genotype 1 Infection

Clinical infectious diseases, 2011-12, Vol.53 (11), p.1111-1114

2011

Volltextzugriff (PDF)

Hepatitis C Virus–Specific CD4+ T Cell Response after Liver Transplantation Occurs Early, Is Multispecific, Compartmentalizes to the Liver, and Does Not Correlate with Recurrent Disease

The Journal of infectious diseases, 2001-04, Vol.183 (8), p.1187-1194

2001

Volltextzugriff (PDF)

Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: A placebo-controlled trial

Hepatology (Baltimore, Md.), 2003-06, Vol.37 (6), p.1359-1367

2003

Volltextzugriff (PDF)

Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany

European journal of gastroenterology & hepatology, 2010-03, Vol.22 (3), p.278-288

2010

Volltextzugriff (PDF)

Differential antigen-processing pathways of the hepatitis B virus e and core proteins

Gastroenterology (New York, N.Y. 1943), 1999-03, Vol.116 (3), p.650-657

1999

Volltextzugriff (PDF)

Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial

European journal of gastroenterology & hepatology, 2007-08, Vol.19 (8), p.639-646

2007

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

ThemaViral Diseases

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(22)
Human Viral Diseases
(22)
Humans
(22)
Infectious Diseases
(22)
Life Sciences & Biomedicine
(22)
Medical Sciences
(22)
Science & Technology
(22)
Viral Hepatitis
(22)
Female
(16)
Gastroenterology & Hepatology
(16)
Male
(16)
Middle Aged
(15)
Adult
(14)
Treatment Outcome
(9)
Acute Disease
(8)
Aged
(8)
Gastroenterology. Liver. Pancreas. Abdomen
(8)
Antiviral Agents - Therapeutic Use
(7)
Hepacivirus - Immunology
(7)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Acute hepatitis C: Current status and remaining challenges

Viral genotype-specific role of PNPLA3 , PPARG , MTTP, and IL28B in hepatitis C virus-associated steatosis

Hepatitis C Virus Infection and Injection Drug Users: Prevention, Risk Factors, and Treatment

Association of Hepatitis C Virus—Specific CD8+ T Cells with Viral Clearance in Acute Hepatitis C

Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy

Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1–infected patients

Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection

Inhibition of Hepatitis C Virus-Like Particle Binding to Target Cells by Antiviral Antibodies in Acute and Chronic Hepatitis C

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance

Detection of functionally altered hepatitis C virus-specific CD4 + T cells in acute and chronic hepatitis C

Antibodies Against Hepatitis C Virus–Like Particles and Viral Clearance in Acute and Chronic Hepatitis C

The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus‐specific CD8+ T‐cell function

Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine

Prediction of treatment outcome in patients with chronic hepatitis C: Significance of baseline parameters and viral dynamics during therapy

Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin

Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination

Importance of Minimal Residual Viremia for Relapse Prediction in Patients With Chronic Hepatitis C Genotype 1 Infection

Hepatitis C Virus–Specific CD4+ T Cell Response after Liver Transplantation Occurs Early, Is Multispecific, Compartmentalizes to the Liver, and Does Not Correlate with Recurrent Disease

Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: A placebo-controlled trial

Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany

Differential antigen-processing pathways of the hepatitis B virus e and core proteins

Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial

Aktive Filter

Suchergebnisse filtern